Fidelity Disruptive Medicine ETF (FMED)
Holdings data is not available for this fund yet.
FMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -0.51% | ▼ -0.51% |
| 3M | ▲ +25.94% | ▲ +25.94% |
| 6M | ▲ +25.94% | ▲ +25.94% |
| YTD | ▲ +17.63% | ▲ +17.63% |
| 1Y | ▲ +25.49% | ▲ +25.49% |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +24.27% | ▲ +24.83% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 70 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY NV | · | $375K | 0.91 | 11,122 | EC | NL |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $338K | 0.82 | 23,554 | EC | US |
| ROIVANT SCIENCES LTD | · | $337K | 0.82 | 11,250 | EC | BM |
| ALIGN TECHNOLOGY INC | 016255101 | $326K | 0.80 | 1,863 | EC | US |
| REPLIGEN CORP | 759916109 | $308K | 0.75 | 2,485 | EC | US |
| ZAI LAB LTD | 98887Q104 | $270K | 0.66 | 15,273 | EC | KY |
| MIRUM PHARMACEUTICALS INC | 604749101 | $222K | 0.54 | 2,191 | EC | US |
| UPSTREAM BIO INC | 91678A107 | $208K | 0.51 | 24,900 | EC | US |
| RELAY THERAPEUTICS INC | 75943R102 | $183K | 0.45 | 12,996 | EC | US |
| STRUCTURE THERAPEUTICS INC | 86366E106 | $182K | 0.44 | 4,628 | EC | KY |
| ZENAS BIOPHARMA INC | 98937L105 | $181K | 0.44 | 9,817 | EC | US |
| VIKING THERAPEUTICS INC | 92686J106 | $178K | 0.43 | 5,422 | EC | US |
| PROCEPT BIOROBOTICS CORP | 74276L105 | $175K | 0.43 | 6,656 | EC | US |
| JANUX THERAPEUTICS INC | 47103J105 | $171K | 0.42 | 11,754 | EC | US |
| OUTSET MEDICAL INC | 690145206 | $166K | 0.41 | 34,000 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $161K | 0.39 | 5,128 | EC | US |
| OLEMA PHARMACEUTICALS INC | 68062P106 | $148K | 0.36 | 11,250 | EC | US |
| Fidelity Revere Street Trust | 31635A105 | $119K | 0.29 | 118,650 | STIV | US |
| ORUKA THERAPEUTICS INC | 687604108 | $59K | 0.14 | 1,000 | EC | US |
| SPYRE THERAPEUTICS INC | 00773J202 | $22K | 0.05 | 300 | EC | US |
Dividends 2 payments
| Ex-date | Amount / share |
|---|---|
| Dec. 20, 2024 | $0.1120 |
| June 21, 2024 | $0.0010 |
Institutional owners (13F) 11 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| FMR LLC | $20,167,655 | 90.89% | 707,017 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $1,422,256 | 6.41% | 49,860 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $282,283 | 1.27% | 9,896 | Shares | June 30, 2026 |
| OLD MISSION CAPITAL LLC | $257,295 | 1.16% | 9,020 | Shares | June 30, 2026 |
| Farther Finance Advisors, LLC | $26,386 | 0.12% | 925 | Shares | June 30, 2026 |
| UBS Group AG | $12,323 | 0.06% | 432 | Shares | June 30, 2026 |
| Parallel Advisors, LLC | $11,239 | 0.05% | 394 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $3,252 | 0.01% | 114 | Shares | June 30, 2026 |
| Central Pacific Bank - Trust Division | $2,767 | 0.01% | 97 | Shares | June 30, 2026 |
| Glen Eagle Advisors, LLC | $2,567 | 0.01% | 90 | Shares | June 30, 2026 |
| Glass Jacobson Investment Advisors llc | $1,427 | 0.01% | 50 | Shares | June 30, 2026 |